Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for maternal anxiety and stress response during C-section
NCT04622202Phase 2Unknown
- Sponsor
- Zagazig University
- Start
- Nov 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pregabalin in anxiety disorder, sponsored by Zagazig University. Primary endpoint: Preoperative maternal anxiety changes at 60 months. Status: unknown.
02
Drugs
pregabalin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04622202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622202.